960
Participants
Start Date
November 30, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
February 28, 2015
AZD4547
Tablets taken, oral, twice daily, commencing with a 2 week on AZD4547, 1 week off AZD4547 schedule.
paclitaxel
Infusion administered once a week, 3 weeks on and 1 week off
Research Site, Brussels (Anderlecht)
Research Site, Brussels (Woluwé-St-Lambert)
Research Site, Leuven
Research Site, Liège
Research Site, Plovdiv
Research Site, Sofia
Research Site, Vratsa
Research Site, Fredericton
Research Site, Toronto
Research Site, Brno
Research Site, Olomouc
Research Site, Prague
Research Site, Saint-Cloud
Research Site, Villejuif
Research Site, Hamburg
Research Site, Mainz
Research Site, Budapest
Research Site, Debrecen
Research Site, Nyíregyháza
Research Site, Bangalore
Research Site, Chennai
Research Site, Hyderabad
Research Site, Nagpur
Research Site, Pune
Research Site, Vellore
Research Site, Ancona
Research Site, Milan
Research Site, Pisa
Research Site, Roma
Research Site, Chiba
Research Site, Chūōku
Research Site, Kōtoku
Research Site, Nagoya
Research Site, Sapporo
Research Site, Takatsuki-shi
Research Site, Brasov
Research Site, Cluj-Napoca
Research Site, Anyang-si
Research Site, Daegu
Research Site, Hwasun-gun
Research Site, Jeonju
Research Site, Seongnam-si
Research Site, Seoul
Research Site, A Coruña
Research Site, Barcelona
Research Site, Madrid
Research Site, Oviedo
Research Site, Santander
Research Site, Seville
Research Site, Keelung
Research Site, Taichung
Research Site, Taipei
Research Site, Taoyuan District
Research Site, Kharkiv
Research Site, Lviv
Research Site, Aberdeen
Research Site, London
Research Site, Maidstone
Research Site, Manchester
Research Site, Sutton
Research Site, Wolverhampton
Lead Sponsor
AstraZeneca
INDUSTRY